Martin N. Wasser
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Response to letter of the editor 'Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions'.
Journal: Familial cancer
Published: March 06, 2025
Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions.
Journal: Familial cancer
Published: November 19, 2023
Feasibility of In Vivo Metal Artifact Reduction in Contrast-Enhanced Dedicated Spiral Breast Computed Tomography.
Journal: Diagnostics (Basel, Switzerland)
Published: August 22, 2023
Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
Journal: The British journal of surgery
Published: September 30, 2020
Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer.
Journal: European journal of radiology
Published: June 15, 2020
Surgical management and pathological assessment of pancreatoduodenectomy with venous resection: an international survey among surgeons and pathologists.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: December 06, 2019
Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: October 01, 2018
High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: January 23, 2018
Balloon dilatation with or without intralesional and oral corticosteroids for anastomotic Crohn's disease strictures.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: December 24, 2015
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 27, 2014
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 04, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026